Reviews in Endocrine and Metabolic Disorders

, Volume 11, Issue 3, pp 179–183

Mutations in pancreatic ß-cell Glucokinase as a cause of hyperinsulinaemic hypoglycaemia and neonatal diabetes mellitus


DOI: 10.1007/s11154-010-9147-z

Cite this article as:
Hussain, K. Rev Endocr Metab Disord (2010) 11: 179. doi:10.1007/s11154-010-9147-z


Glucokinase is a key enzyme involved in regulating insulin secretion from the pancreatic ß-cell. The unique role of glucokinase in human glucose physiology is illustrated by the fact that genetic mutations in glucokinase can either cause hyperglycaemia or hypoglycaemia. Heterozygous inactivating mutations in glucokinase cause maturity-onset diabetes of the young (MODY), homozygous inactivating in glucokinase mutations result in permanent neonatal diabetes whereas heterozygous activating glucokinase mutations cause hyperinsulinaemic hypoglycaemia


GlucoseInsulinGlucokinaseHypoglycaemiaNeonatal diabetes mellitus

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Clinical and Molecular Genetics Unit, The Developmental Endocrinology Research Group, Institute of Child Health, Hospital for Children NHS TrustUniversity College LondonLondonUK
  2. 2.Developmental Endocrinology Research Group, Clinical and Molecular Genetics Unit, Institute of Child HealthUniversity College LondonLondonUK